The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy

Conclusions: A2BAR modulators may provide new therapeutic options to retard CsA nephropathy by mediating renal VEGF and NO.

Source: Journal of Pharmacology and Pharmacotherapeutics - August 4, 2015 Category: Drugs & Pharmacology Authors: Leena PatelAswin Thaker Source Type: research